166
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Kozeny–Carman permeability relationship with disintegration process predicted from early dissolution profiles of immediate release tablets

, , , , &
Pages 1143-1153 | Received 03 Sep 2016, Accepted 21 Feb 2017, Published online: 14 Mar 2017

References

  • FDA. Orally disintegrating tablets. Guidance for industry. Guidance for industry: bioavailability and bioequivalence studies for orally administered drug products-general considerations. Rockville (MD): Division of Drug Information, Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA); 2002.
  • EMEA. Guideline on the investigation of bioequivalence. London: UK European Medicines Agency; 2008.
  • Lionberger RA, Raw AS, Kim SH, et al. Use of partial AUC to demonstrate bioequivalence of zolpidem tartrate extended release formulations. Pharm Res 2012;29:1110–20.
  • Schiermeier S, Schmidt PC. Fast dispersible ibuprofen tablets. Eur J Pharm Sci 2002;15:295–305.
  • Narazaki R, Harada T, Takami N, et al. A new method for disintegration studies of rapid disintegrating tablet. Chem Pharm Bull 2004;52:704–7.
  • Cartwright MAC. The British pharmacopoeia, 1864 to 2014: medicines, international standards and the state. Surrey, England: Ashgate Publishing, Ltd.; 2015.
  • Lee B-J. Pharmaceutical preformulation: physicochemical properties of excipients and powders and tablet characterization. Pharmaceutical manufacturing handbook. Hoboken, NJ: John Wiley & Sons, Inc.; 2008:879–931.
  • Gibaldi M, Perrier D. Method of residuals. Appendix c. Pharmacokinetics. Drugs and pharmaceutical sciences. 2nd ed. New York: Informa Healthcare USA; 2007:433–44.
  • Nelson KG, Wang LY. Determination of time course of tablet disintegration II: method using continuous functions. J Pharm Sci 1978;67:86–9.
  • Nelson KG, Wang LY. Determination of time course of tablet disintegration I: numerical method. J Pharm Sci 1977;66:1758–61.
  • Cruaud O, Duchěne D, Puisieux F, Carstensen JT. Correlation between porosity and dissolution rate constants for disintegrating tablets. J Pharm Sci 1980;69:607–8.
  • Horkovics-Kovats S. Disintegration rate and properties of active pharmaceutical ingredient particles as determined from the dissolution time profile of a pharmaceutical formulation: an inverse problem. J Pharm Sci 2014;103:456–64.
  • Battu SK, Repka MA, Majumdar S, Rao YM. Formulation and evaluation of rapidly disintegrating fenoverine tablets: effect of superdisintegrants. Drug Dev Ind Pharm 2007;33:1225–32.
  • Braido D, Gulak Y, Cuitino A. Solvent penetration rate in tablet measurement using video image processing. AAPS PharmSciTech 2012;13:507–12.
  • Niazi SK. Bioequivalence regulatory compliance. Handbook of pharmaceutical manufacturing formulations. 02. 2nd ed. London: Informa UK Limited; 2004.
  • Yassin S, Goodwin DJ, Anderson A, et al. The disintegration process in microcrystalline cellulose based tablets, part 1: influence of temperature, porosity and superdisintegrants. J Pharm Sci 2015;104:3440–50.
  • Massimo G, Catellani PL, Santi P, et al. Disintegration propensity of tablets evaluated by means of disintegrating force kinetics. Pharm Dev Technol 2000;5:163–9.
  • Koponen A, Kandhai D, Hellén E, et al. Permeability of three-dimensional random fiber webs. Phys Rev Lett 1998;80:716–19.
  • Clennell MB. Tortuosity: a guide through the maze. Geol Soc Lond Spec Publ 1997;122:299–344.
  • Heijs AWJ, Lowe CP. Numerical evaluation of the permeability and the Kozeny constant for two types of porous media. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics 1995;51:4346–52.
  • Chapuis RP, Aubertin M. On the use of the Kozeny–Carman equation to predict the hydraulic conductivity of soils. Can Geotech J 2003;40:616–28.
  • Backhurst JR, Harker JH, Richardson JF. Flow of fluids through granular beds and packed columns. Chemical engineering. Oxford, UK: Elsevier BV; 2002:34–8.
  • Knackstedt MA, Zhang X. Direct evaluation of length scales and structural parameters associated with flow in porous media. Phys Rev E 1994;50:2134–8.
  • USP31/NF26. General chapter. The United State Pharmacopoeia and National Formulary. United States Pharmacopeia-National Formulary: The United States Pharmacopeial Convention; 2008.
  • Pitt KG, Newton JM, Richardson R, Stanley P. The material tensile strength of convex-faced aspirin tablets. J Pharm Pharmacol 1989;41:289–92.
  • LeBlond D, Altan S, Novick S, et al. In vitro dissolution curve comparisons: a critique of current practice. Dissolut Technol 2016;23:14–23.
  • Yáñez JA, Remsberg CM, Sayre CL, et al. Flip-flop pharmacokinetics – delivering a reversal of disposition: challenges and opportunities during drug development. Ther Deliv 2011;2:643–72.
  • Wilson D, Wren S, Reynolds G. Linking dissolution to disintegration in immediate release tablets using image analysis and a population balance modelling approach. Pharm Res 2012;29:198–208.
  • Masteau JC, Thomas G. Modelling to understand porosity and specific surface area changes during tabletting. Powder Technol 1999;101:240–8.
  • Bi YX, Sunada H, Yonezawa Y, Danjo K. Evaluation of rapidly disintegrating tablets prepared by a direct compression method. Drug Dev Ind Pharm 1999;25:571–81.
  • Khossravi D, Morehead WT. Consolidation mechanisms of pharmaceutical solids: a multi-compression cycle approach. Pharm Res 1997;14:1039–45.
  • Rajkumar AD, Reynolds GK, Wilson D, et al. Investigating the effect of processing parameters on pharmaceutical tablet disintegration using a real-time particle imaging approach. Eur J Pharm Biopharm 2016;106:88–96.
  • Abdelbary G, Eouani C, Prinderre P, et al. Determination of the in vitro disintegration profile of rapidly disintegrating tablets and correlation with oral disintegration. Int J Pharm 2005;292:29–41.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.